French Competition Regulator Probes Roche, Novartis AG

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

France’s competition authority is investigating Novartis AG (NOVN) and Roche Holding AG (ROG) for possible collusion to prevent the use of Roche’s Avastin cancer drug as a treatment for an eye disease, the health-care ministry said.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC